Announcements

We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Nanomedicine and Nanotechnology”. The paper list is as follows:

1. “Methods of Liposomes Preparation: Formation and Control Factors of Versatile Nanocarriers for Biomedical and Nanomedicine Application”
by Domenico Lombardo and Mikhail A. Kiselev
Pharmaceutics 2022, 14(3), 543; https://doi.org/10.3390/pharmaceutics14030543
Available online: https://www.mdpi.com/1999-4923/14/3/543

2. “An Overview of Nanotechnologies for Drug Delivery to the Brain”
by Ahsan Ayub and Shawn Wettig
Pharmaceutics 2022, 14(2), 224; https://doi.org/10.3390/pharmaceutics14020224
Available online: https://www.mdpi.com/1999-4923/14/2/224

3. “Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma”
by Maria João Ramalho, Joana Angélica Loureiro, Manuel A. N. Coelho and Maria Carmo Pereira
Pharmaceutics 2022, 14(2), 279; https://doi.org/10.3390/pharmaceutics14020279
Available online: https://www.mdpi.com/1999-4923/14/2/279

4. “Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation”
by Hanhee Cho, Seong Ik Jeon, Cheol-Hee Ahn, Man Kyu Shim and Kwangmeyung Kim
Pharmaceutics 2022, 14(4), 728; https://doi.org/10.3390/pharmaceutics14040728
Available online: https://www.mdpi.com/1999-4923/14/4/728

5. “Silica-Based Stimuli-Responsive Systems for Antitumor Drug Delivery and Controlled Release”
by Avelino Corma, Pablo Botella and Eva Rivero-Buceta
Pharmaceutics 2022, 14(1), 110; https://doi.org/10.3390/pharmaceutics14010110
Available online: https://www.mdpi.com/1999-4923/14/1/110

6. “Glioblastoma-Derived Exosomes as Nanopharmaceutics for Improved Glioma Treatment”
by Hyeji Lee, Kanghye Bae, Ah-Rum Baek, Eun-Bin Kwon, Yeoun-Hee Kim, Sung-Wook Nam, Gang Ho Lee and Yongmin Chang
Pharmaceutics 2022, 14(5), 1002; https://doi.org/10.3390/pharmaceutics14051002
Available online: https://www.mdpi.com/1999-4923/14/5/1002

7. “Superparamagnetic Iron Oxide Nanoparticles Decorated Mesoporous Silica Nanosystem for Combined Antibiofilm Therapy”
by Elena Álvarez, Manuel Estévez, Alvaro Gallo-Cordova, Blanca González, Rafael R. Castillo, María del Puerto Morales, Montserrat Colilla, Isabel Izquierdo-Barba and María Vallet-Regí
Pharmaceutics 2022, 14(1), 163; https://doi.org/10.3390/pharmaceutics14010163
Available online: https://www.mdpi.com/1999-4923/14/1/163

8. “mRNA-Loaded Lipid Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy”
by Kosuke Sasaki, Yusuke Sato, Kento Okuda, Kazuki Iwakawa and Hideyoshi Harashima
Pharmaceutics 2022, 14(8), 1572; https://doi.org/10.3390/pharmaceutics14081572
Available online: https://www.mdpi.com/1999-4923/14/8/1572

9. “Cu-Doped Hollow Bioactive Glass Nanoparticles for Bone Infection Treatment”
by Javier Jiménez-Holguín, Sandra Sánchez-Salcedo, Mónica Cicuéndez, María Vallet-Regí and Antonio J. Salinas
Pharmaceutics 2022, 14(4), 845; https://doi.org/10.3390/pharmaceutics14040845
Available online: https://www.mdpi.com/1999-4923/14/4/845

10. “A Unique Core—Shell Structured, Glycol Chitosan-Based Nanoparticle Achieves Cancer-Selective Gene Delivery with Reduced Off-Target Effects”
by Bei Cheng, Hye-Hyun Ahn, Hwanhee Nam, Zirui Jiang, Feng J. Gao, Il Minn and Martin G. Pomper
Pharmaceutics 2022, 14(2), 373; https://doi.org/10.3390/pharmaceutics14020373
Available online: https://www.mdpi.com/1999-4923/14/2/373

You can check all publications in the Section “Nanomedicine and Nanotechnology” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1027.

We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Gene and Cell Therapy”. The paper list is as follows:

1. “Peptides vs. Polymers: Searching for the Most Efficient Delivery System for Mitochondrial Gene Therapy“
by Rúben Faria, Milan Paul, Swati Biswas, Eric Vivès, Prisca Boisguérin, Ângela Sousa and Diana Costa
Pharmaceutics 2022, 14(4), 757; https://doi.org/10.3390/pharmaceutics14040757
Available online: https://www.mdpi.com/1999-4923/14/4/757

2. “IFN-α/β Signaling Is Required for CDG-Mediated CTL Generation and B Lymphocyte Activation”
by Ahmed E. I. Hamouda, Kai Schulze, Thomas Ebensen, Carlos Alberto Guzmán and Darío Lirussi
Pharmaceutics 2022, 14(12), 2821; https://doi.org/10.3390/pharmaceutics14122821
Available online: https://www.mdpi.com/1999-4923/14/12/2821

3. “Effervescent Atomizer as Novel Cell Spray Technology to Decrease the Gas-to-Liquid Ratio”
by Anja Lena Thiebes, Sarah Klein, Jonas Zingsheim, Georg H. Möller, Stefanie Gürzing, Manuel A. Reddemann, Mehdi Behbahani, Stefan Jockenhoevel and Christian G. Cornelissen
Pharmaceutics 2022, 14(11), 2421; https://doi.org/10.3390/pharmaceutics14112421
Available online: https://www.mdpi.com/1999-4923/14/11/2421

4. “Development of a Combined Lipid-Based Nanoparticle Formulation for Enhanced siRNA Delivery to Vascular Endothelial Cells”
by Yutong He, Dongdong Bi, Josée A. Plantinga, Grietje Molema, Jeroen Bussmann and Jan A. A. M. Kamps
Pharmaceutics 2022, 14(10), 2086; https://doi.org/10.3390/pharmaceutics14102086
Available online: https://www.mdpi.com/1999-4923/14/10/2086

5. “Development of WRAP5 Peptide Complexes for Targeted Drug/Gene Co-Delivery toward Glioblastoma Therapy“
by Ana Raquel Neves, Tânia Albuquerque, Rúben Faria, Ana M. Gonçalves, Cecília Santos, Eric Vivès, Prisca Boisguérin, Luís A. Passarinha, Ângela Sousa and Diana Costa
Pharmaceutics 2022, 14(10), 2213; https://doi.org/10.3390/pharmaceutics14102213
Available online: https://www.mdpi.com/1999-4923/14/10/2213

6. “Non-Viral Delivery of CRISPR/Cas Cargo to the Retina Using Nanoparticles: Current Possibilities, Challenges, and Limitations”
by Ahmed Salman, Ariel Kantor, Michelle E. McClements, Gemma Marfany, Sonia Trigueros and Robert E. MacLaren
Pharmaceutics 2022, 14(9), 1842; https://doi.org/10.3390/pharmaceutics14091842
Available online: https://www.mdpi.com/1999-4923/14/9/1842

7. “The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA”
by Laura Taina-González and María de la Fuente
Pharmaceutics 2022, 14(2), 460; https://doi.org/10.3390/pharmaceutics14020460
Available online: https://www.mdpi.com/1999-4923/14/2/460

8. “A Narrative Review of Cell-Based Approaches for Cranial Bone Regeneration”
by Maria I. Falguera Uceda, Silvia Sánchez-Casanova, Clara Escudero-Duch and Nuria Vilaboa
Pharmaceutics 2022, 14(1), 132; https://doi.org/10.3390/pharmaceutics14010132
Available online: https://www.mdpi.com/1999-4923/14/1/132

You can check all publications in the Section “Gene and Cell Therapy” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1033.

We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Physical Pharmacy and Formulation”. The paper list is as follows:

1. "Polysaccharide 3D Printing for Drug Delivery Applications"
by Alexandra Zamboulis, Georgia Michailidou, Ioanna Koumentakou and Dimitrios N. Bikiaris
Pharmaceutics 2022, 14(1), 145; https://doi.org/10.3390/pharmaceutics14010145
Available online: https://www.mdpi.com/1999-4923/14/1/145

2. "Engineering the Surface of Ti₃C₂ MXene Nanosheets for High Stability and Multimodal Anticancer Therapy"
by Chiranjeevi Korupalli, Kai-Long You, Girum Getachew, Akash S. Rasal, Worku Batu Dirersa, Mochamad Zakki Fahmi and Jia-Yaw Chang
Pharmaceutics 2022, 14(2), 304; https://doi.org/10.3390/pharmaceutics14020304
Available online: https://www.mdpi.com/1999-4923/14/2/304

3. "Chemical Composition and Effect against Skin Alterations of Bioactive Extracts Obtained by the Hydrodistillation of Eucalyptus globulus Leaves"
by Patrícia Moreira, Fábio Jesus Sousa, Patrícia Matos, Gonçalo Sousa Brites, Maria José Gonçalves, Carlos Cavaleiro, Artur Figueirinha, Lígia Salgueiro, Maria Teresa Batista, Pedro Costa Branco et al.
Pharmaceutics 2022, 14(3), 561; https://doi.org/10.3390/pharmaceutics14030561
Available online: https://www.mdpi.com/1999-4923/14/3/561

4. "3D Printing of Pediatric Medication: The End of Bad Tasting Oral Liquids?—A Scoping Review"
by Iris Lafeber, Elisabeth J. Ruijgrok, Henk-Jan Guchelaar and Kirsten J. M. Schimmel
Pharmaceutics 2022, 14(2), 416; https://doi.org/10.3390/pharmaceutics14020416
Available online: https://www.mdpi.com/1999-4923/14/2/416

5. "Polymeric Nanocapsules Containing Fennel Essential Oil: Their Preparation, Physicochemical Characterization, Stability over Time and in Simulated Gastrointestinal Conditions"
by Giuseppe Granata, Carla Riccobene, Edoardo Napoli and Corrada Geraci
Pharmaceutics 2022, 14(4), 873; https://doi.org/10.3390/pharmaceutics14040873
Available online: https://www.mdpi.com/1999-4923/14/4/873

6. "Biodegradable and Bioactive Carriers Based on Poly(betulin disuccinate-co-sebacic Acid) for Rifampicin Delivery"
by Daria Niewolik, Barbara Bednarczyk-Cwynar, Piotr Ruszkowski, Alicja Kazek-Kęsik, Grzegorz Dzido and Katarzyna Jaszcz
Pharmaceutics 2022, 14(3), 579; https://doi.org/10.3390/pharmaceutics14030579
Available online: https://www.mdpi.com/1999-4923/14/3/579

7. "Drug Stability: ICH versus Accelerated Predictive Stability Studies"
by Olga González-González, Irving O. Ramirez, Bianca I. Ramirez, Peter O’Connell, Maria Paloma Ballesteros, Juan José Torrado and Dolores R. Serrano
Pharmaceutics 2022, 14(11), 2324; https://doi.org/10.3390/pharmaceutics14112324
Available online: https://www.mdpi.com/1999-4923/14/11/2324

8. "Moxifloxacin Liposomes: Effect of Liposome Preparation Method on Physicochemical Properties and Antimicrobial Activity against Staphylococcus epidermidis"
by Evangelos Natsaridis, Foteini Gkartziou, Spyridon Mourtas, Marc C. A. Stuart, Fevronia Kolonitsiou, Pavlos Klepetsanis, Iris Spiliopoulou and Sophia G. Antimisiaris
Pharmaceutics 2022, 14(2), 370; https://doi.org/10.3390/pharmaceutics14020370
Available online: https://www.mdpi.com/1999-4923/14/2/370

9. "Skin Regenerative Potential of Cupuaçu Seed Extract (Theobroma grandiflorum), a Native Fruit from the Amazon: Development of a Topical Formulation Based on Chitosan-Coated Nanocapsules"
by Geisa Nascimento Barbalho, Breno Noronha Matos, Gabriel Ferreira da Silva Brito, Thamires da Cunha Miranda, Thuany Alencar-Silva, Fernando Fabriz Sodré, Guilherme Martins Gelfuso, Marcilio Cunha-Filho, Juliana Lott Carvalho, Joyce Kelly do Rosário da Silva et al.
Pharmaceutics 2022, 14(1), 207; https://doi.org/10.3390/pharmaceutics14010207
Available online: https://www.mdpi.com/1999-4923/14/1/207

10. "Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release"
by David Encinas-Basurto, John P. Konhilas, Robin Polt, Meredith Hay and Heidi M. Mansour
Pharmaceutics 2022, 14(3), 587; https://doi.org/10.3390/pharmaceutics14030587
Available online: https://www.mdpi.com/1999-4923/14/3/587

You can check all publications in the Section “Physical Pharmacy and Formulation” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1029.

We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Pharmacokinetics and Pharmacodynamics”. The paper list is as follows:

1. “Toxicokinetics of β-Amanitin in Mice and In Vitro Drug–Drug Interaction Potential”
by Young Yoon Bang, Im-Sook Song, Min Seo Lee, Chang Ho Lim, Yong-Yeon Cho, Joo Young Lee, Han Chang Kang and Hye Suk Lee
Pharmaceutics 2022, 14(4), 774; https://doi.org/10.3390/pharmaceutics14040774
Available online: https://www.mdpi.com/1999-4923/14/4/774

2. “Physiologically Based Pharmacokinetic (PBPK) Model of Gold Nanoparticle-Based Drug Delivery System for Stavudine Biodistribution”
by Hinojal Zazo, Clara I. Colino, Carmen Gutiérrez-Millán, Andres A. Cordero, Matthias Bartneck and José M. Lanao
Pharmaceutics 2022, 14(2), 406; https://doi.org/10.3390/pharmaceutics14020406
Available online: https://www.mdpi.com/1999-4923/14/2/406

3. “Adoption of Machine Learning in Pharmacometrics: An Overview of Recent Implementations and Their Considerations”
by Alexander Janssen, Frank C. Bennis and Ron A. A. Mathôt
Pharmaceutics 2022, 14(9), 1814; https://doi.org/10.3390/pharmaceutics14091814
Available online: https://www.mdpi.com/1999-4923/14/9/1814

4. “Pharmacophore-Based Discovery of Substrates of a Novel Drug/Proton-Antiporter in the Human Brain Endothelial hCMEC/D3 Cell Line”
by Maria Smirnova, Laura Goracci, Gabriele Cruciani, Laetitia Federici, Xavier Declèves, Hélène Chapy and Salvatore Cisternino
Pharmaceutics 2022, 14(2), 255; https://doi.org/10.3390/pharmaceutics14020255
Available online: https://www.mdpi.com/1999-4923/14/2/255

5. “Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis”
by Karine Rodríguez-Fernández, Víctor Mangas-Sanjuán, Matilde Merino-Sanjuán, Antonio Martorell-Calatayud, Almudena Mateu-Puchades, Mónica Climente-Martí and Elena Gras-Colomer
Pharmaceutics 2022, 14(3), 654; https://doi.org/10.3390/pharmaceutics14030654
Available online: https://www.mdpi.com/1999-4923/14/3/654

6. “Semi-Automated Therapeutic Drug Monitoring as a Pillar toward Personalized Medicine for Tuberculosis Management”
by Rannissa Puspita Jayanti, Nguyen Phuoc Long, Nguyen Ky Phat, Yong-Soon Cho and Jae-Gook Shin
Pharmaceutics 2022, 14(5), 990; https://doi.org/10.3390/pharmaceutics14050990
Available online: https://www.mdpi.com/1999-4923/14/5/990

7. “Physiologically Based Pharmacokinetic (PBPK) Modeling of Clopidogrel and Its Four Relevant Metabolites for CYP2B6, CYP2C8, CYP2C19, and CYP3A4 Drug–Drug–Gene Interaction Predictions”
by Helena Leonie Hanae Loer, Denise Türk, José David Gómez-Mantilla, Dominik Selzer and Thorsten Lehr
Pharmaceutics 2022, 14(5), 915; https://doi.org/10.3390/pharmaceutics14050915
Available online: https://www.mdpi.com/1999-4923/14/5/915

8. “Interaction of Antifungal Drugs with CYP3A- and OATP1B-Mediated Venetoclax Elimination”
by Eric D. Eisenmann, Dominique A. Garrison, Zahra Talebi, Yan Jin, Josie A. Silvaroli, Jin-Gyu Kim, Alex Sparreboom, Michael R. Savona, Alice S. Mims and Sharyn D. Baker
Pharmaceutics 2022, 14(4), 694; https://doi.org/10.3390/pharmaceutics14040694
Available online: https://www.mdpi.com/1999-4923/14/4/694

9. “Integration of a Physiologically Based Pharmacokinetic and Pharmacodynamic Model for Tegoprazan and Its Metabolite: Application for Predicting Food Effect and Intragastric pH Alterations”
by Hyeon-Cheol Jeong, Min-Gul Kim, Zhuodu Wei, Kyeong-Ryoon Lee, Jaehyeok Lee, Im-Sook Song and Kwang-Hee Shin
Pharmaceutics 2022, 14(6), 1298; https://doi.org/10.3390/pharmaceutics14061298
Available online: https://www.mdpi.com/1999-4923/14/6/1298

You can check all publications in the Section “Pharmacokinetics and Pharmacodynamics” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1032.

We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Pharmaceutical Technology, Manufacturing and Devices”. The paper list is as follows:

1. “Strategies to Improve Drug Strength in Nasal Preparations for Brain Delivery of Low Aqueous Solubility Drugs”
by Patrícia C. Pires, Márcio Rodrigue, Gilberto Alves and Adriana O. Santos
Pharmaceutics 2022, 14(3), 588; https://doi.org/10.3390/pharmaceutics14030588
Available online: https://www.mdpi.com/1999-4923/14/3/588

2. “The Evolution of the 3D-Printed Drug Delivery Systems: A Review”
by Ildikó Bácskay, Zoltán Ujhelyi, Pálma Fehér and Petra Arany
Pharmaceutics 2022, 14(7), 1312; https://doi.org/10.3390/pharmaceutics14071312
Available online: https://www.mdpi.com/1999-4923/14/7/1312

3. “Dry Powder Comprised of Isoniazid-Loaded Nanoparticles of Hyaluronic Acid in Conjugation with Mannose-Anchored Chitosan for Macrophage-Targeted Pulmonary Administration in Tuberculosis”
by Mahwash Mukhtar, Noemi Csaba, Sandra Robla, Rubén Varela-Calviño, Attila Nagy, Katalin Burian, Dávid Kókai and Rita Ambrus
Pharmaceutics 2022, 14(8), 1543; https://doi.org/10.3390/pharmaceutics14081543
Available online: https://www.mdpi.com/1999-4923/14/8/1543

4. “Inhaled Antifungal Agents for Treatment and Prophylaxis of Bronchopulmonary Invasive Mold Infections”
by Kévin Brunet, Jean-Philippe Martellosio, Frédéric Tewes, Sandrine Marchand and Blandine Rammaert
Pharmaceutics 2022, 14(3), 641; https://doi.org/10.3390/pharmaceutics14030641
Available online: https://www.mdpi.com/1999-4923/14/3/641

5. “Assessment of the Extrusion Process and Printability of Suspension-Type Drug-Loaded AffinisolTM Filaments for 3D Printing”
by Gloria Mora-Castaño, Mónica Millán-Jiménez, Vicente Linares and Isidoro Caraballo
Pharmaceutics 2022, 14(4), 871; https://doi.org/10.3390/pharmaceutics14040871
Available online: https://www.mdpi.com/1999-4923/14/4/871

6. “Emerging Artificial Intelligence (AI) Technologies Used in the Development of Solid Dosage Forms”
by Junhuang Jiang, Xiangyu Ma, Defang Ouyang and Robert O. Williams III
Pharmaceutics 2022, 14(11), 2257; https://doi.org/10.3390/pharmaceutics14112257
Available online: https://www.mdpi.com/1999-4923/14/11/2257

7. “Creating Acceptable Tablets 3D (CAT 3D): A Feasibility Study to Evaluate the Acceptability of 3D Printed Tablets in Children and Young People”
by Louise Bracken, Rober Habashy, Emma McDonough, Fiona Wilson, Joanne Shakeshaft, Udeme Ohia, Tamar Garcia-Sorribes, Abdullah Isreb, Mohamed A. Alhnan and Matthew Peak
Pharmaceutics 2022, 14(3), 516; https://doi.org/10.3390/pharmaceutics14030516
Available online: https://www.mdpi.com/1999-4923/14/3/516

8. ”QbD Consideration for Developing a Double-Layered Tablet into a Single-Layered Tablet with Telmisartan and Amlodipine”
by Joo-Eun Kim and Young-Joon Park
Pharmaceutics 2022, 14(2), 377; https://doi.org/10.3390/pharmaceutics14020377
Available online: https://www.mdpi.com/1999-4923/14/2/377

9. “Progress in 3D Bioprinting Technology for Osteochondral Regeneration”
by Markel Lafuente-Merchan, Sandra Ruiz-Alonso, Fátima García-Villén, Idoia Gallego, Patricia Gálvez-Martín, Laura Saenz-del-Burgo and Jose Luis Pedraz
Pharmaceutics 2022, 14(8), 1578; https://doi.org/10.3390/pharmaceutics14081578
Available online: https://www.mdpi.com/1999-4923/14/8/1578

10. “Nanoforming Hyaluronan-Based Thermoresponsive Hydrogels: Optimized and Tunable Functionality in Osteoarthritis Management”
by Alexandre Porcello, Paula Gonzalez-Fernandez, Olivier Jordan and Eric Allémann
Pharmaceutics 2022, 14(3), 659; https://doi.org/10.3390/pharmaceutics14030659
Available online: https://www.mdpi.com/1999-4923/14/3/659

You can check all publications in the Section “Pharmaceutical Technology, Manufacturing and Devices” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1028.

We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Drug Targeting and Design”. The paper list is as follows:

1. “Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives”
by Teresa Pardo-Moreno, Anabel González-Acedo, Antonio Rivas-Domínguez, Victoria García-Morales, Francisco Jose García-Cozar, Juan Jose Ramos-Rodríguez and Lucía Melguizo-Rodríguez
Pharmaceutics 2022, 14(6), 1117; https://doi.org/10.3390/pharmaceutics14061117
Available online: https://www.mdpi.com/1999-4923/14/6/1117

2. “Tissue Adhesive, Self-Healing, Biocompatible, Hemostasis, and Antibacterial Properties of Fungal-Derived Carboxymethyl Chitosan-Polydopamine Hydrogels”
by Kummara Madhusudana Rao, Kannan Badri Narayanan, Uluvangada Thammaiah Uthappa, Pil-Hoon Park, Inho Choi and Sung Soo Han
Pharmaceutics 2022, 14(5), 1028; https://doi.org/10.3390/pharmaceutics14051028
Available online: https://www.mdpi.com/1999-4923/14/5/1028

3. “Novel Nanoparticles Based on N,O-Carboxymethyl Chitosan-Dopamine Amide Conjugate for Nose-to-Brain Delivery”
by Adriana Trapani, Stefania Cometa, Elvira De Giglio, Filomena Corbo, Roberta Cassano, Maria Luisa Di Gioia, Sonia Trombino, Md Niamat Hossain, Sante Di Gioia, Giuseppe Trapani et al.
Pharmaceutics 2022, 14(1), 147; https://doi.org/10.3390/pharmaceutics14010147
Available online: https://www.mdpi.com/1999-4923/14/1/147

4. “Advantageous Reactivity of Unstable Metal Complexes: Potential Applications of Metal-Based Anticancer Drugs for Intratumoral Injections”
by Aviva Levina, Debbie C. Crans and Peter A. Lay
Pharmaceutics 2022, 14(4), 790; https://doi.org/10.3390/pharmaceutics14040790
Available online: https://www.mdpi.com/1999-4923/14/4/790

5. “Fluoroquinolones Hybrid Molecules as Promising Antibacterial Agents in the Fight against Antibacterial Resistance”
by Ioana-Andreea Lungu, Octavia-Laura Moldovan, Victoria Biriș and Aura Rusu
Pharmaceutics 2022, 14(8), 1749; https://doi.org/10.3390/pharmaceutics14081749
Available online: https://www.mdpi.com/1999-4923/14/8/1749

6. “Chemically Modified Extracellular Vesicles and Applications in Radiolabeling and Drug Delivery”
by Elisa-Racky N’Diaye, Nicola Salvatore Orefice, Catherine Ghezzi and Ahcène Boumendjel
Pharmaceutics 2022, 14(3), 653; https://doi.org/10.3390/pharmaceutics14030653
Available online: https://www.mdpi.com/1999-4923/14/3/653

7. “Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity”
by Aleen Khoury, Jennette A. Sakoff, Jayne Gilbert, Kieran F. Scott, Shawan Karan, Christopher P. Gordon and Janice R. Aldrich-Wright
Pharmaceutics 2022, 14(4), 787; https://doi.org/10.3390/pharmaceutics14040787
Available online: https://www.mdpi.com/1999-4923/14/4/787

8. “Alternative Antibiotics in Dentistry: Antimicrobial Peptides”
by Alexandra Griffith, Akilah Mateen, Kenneth Markowitz, Steven R. Singer, Carla Cugini, Emi Shimizu, Gregory R. Wiedman and Vivek Kumar
Pharmaceutics 2022, 14(8), 1679; https://doi.org/10.3390/pharmaceutics14081679
Available online: https://www.mdpi.com/1999-4923/14/8/1679

9. “The Importance of Endoplasmic Reticulum Stress as a Novel Antidepressant Drug Target and Its Potential Impact on CNS Disorders”
by Marta Jóźwiak-Bębenista, Paulina Sokołowska, Małgorzata Siatkowska, Cecilia Analia Panek, Piotr Komorowski, Edward Kowalczyk and Anna Wiktorowska-Owczarek
Pharmaceutics 2022, 14(4), 846; https://doi.org/10.3390/pharmaceutics14040846
Available online: https://www.mdpi.com/1999-4923/14/4/846

10. “Synthesis and Biological Evaluation of Highly Active 7-Anilino Triazolopyrimidines as Potent Antimicrotubule Agents”
by Paola Oliva, Romeo Romagnoli, Barbara Cacciari, Stefano Manfredini, Chiara Padroni, Andrea Brancale, Salvatore Ferla, Ernest Hamel, Diana Corallo, Sanja Aveic et al.
Pharmaceutics 2022, 14(6), 1191; https://doi.org/10.3390/pharmaceutics14061191
Available online: https://www.mdpi.com/1999-4923/14/6/1191

You can check all publications in the Section “Drug Targeting and Design” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1034.

We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Drug Delivery and Controlled Release”. The paper list is as follows:

1. “Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System”
by Tyler P. Crowe and Walter H. Hsu
Pharmaceutics 2022, 14(3), 629; https://doi.org/10.3390/pharmaceutics14030629
Available online: https://www.mdpi.com/1999-4923/14/3/629

2. “A Historical Review of Brain Drug Delivery”
by William M. Pardridge
Pharmaceutics 2022, 14(6), 1283; https://doi.org/10.3390/pharmaceutics14061283
Available online: https://www.mdpi.com/1999-4923/14/6/1283

3. “EGFR-Targeted Photodynamic Therapy”
by Luca Ulfo, Paolo Emidio Costantini, Matteo Di Giosia, Alberto Danielli and Matteo Calvaresi
Pharmaceutics 2022, 14(2), 241; https://doi.org/10.3390/pharmaceutics14020241
Available online: https://www.mdpi.com/1999-4923/14/2/241

4. “Redesigning of Cell-Penetrating Peptides to Improve Their Efficacy as a Drug Delivery System”
by Ildikó Szabó, Mo’ath Yousef, Dóra Soltész, Csaba Bató, Gábor Mező and Zoltán Bánóczi
Pharmaceutics 2022, 14(5), 907; https://doi.org/10.3390/pharmaceutics14050907
Available online: https://www.mdpi.com/1999-4923/14/5/907

5. “Honey: An Advanced Antimicrobial and Wound Healing Biomaterial for Tissue Engineering Applications”
by Joel Yupanqui Mieles, Cian Vyas, Enes Aslan, Gavin Humphreys, Carl Diver and Paulo Bartolo
Pharmaceutics 2022, 14(8), 1663; https://doi.org/10.3390/pharmaceutics14081663
Available online: https://www.mdpi.com/1999-4923/14/8/1663

6. “Molecular Tuning of IR-786 for Improved Tumor Imaging and Photothermal Therapy”
by Wonbong Lim, Jae Yong Byun, Gayoung Jo, Eun Jeong Kim, Min Ho Park and Hoon Hyun
Pharmaceutics 2022, 14(3), 676; https://doi.org/10.3390/pharmaceutics14030676
Available online: https://www.mdpi.com/1999-4923/14/3/676

7. “Novel Methacrylate-Based Multilayer Nanofilms with Incorporated FePt-Based Nanoparticles and the Anticancer Drug 5-Fluorouracil for Skin Cancer Treatment”
by Kristijan Skok, Tanja Zidarič, Kristjan Orthaber, Matevž Pristovnik, Nina Kostevšek, Kristina Žužek Rožman, Sašo Šturm, Lidija Gradišnik, Uroš Maver and Tina Maver
Pharmaceutics 2022, 14(4), 689; https://doi.org/10.3390/pharmaceutics14040689
Available online: https://www.mdpi.com/1999-4923/14/4/689

8. “Formulation and Biological Evaluation of Mesoporous Silica Nanoparticles Loaded with Combinations of Sortase A Inhibitors and Antimicrobial Peptides”
by Sitah Alharthi, Zyta M. Ziora, Taskeen Janjua, Amirali Popat and Peter M. Moyle
Pharmaceutics 2022, 14(5), 986; https://doi.org/10.3390/pharmaceutics14050986
Available online: https://www.mdpi.com/1999-4923/14/5/986

9. “Design and Validation of Nanofibers Made of Self-Assembled Peptides to Become Multifunctional Stimuli-Sensitive Nanovectors of Anticancer Drug Doxorubicin”
by Valentina Del Genio, Annarita Falanga, Emilie Allard-Vannier, Katel Hervé-Aubert, Marilisa Leone, Rosa Bellavita, Rustem Uzbekov, Igor Chourpa and Stefania Galdie
Pharmaceutics 2022, 14(8), 1544; https://doi.org/10.3390/pharmaceutics14081544
Available online: https://www.mdpi.com/1999-4923/14/8/1544

10. “Evaluation of the Mucoadhesive Properties of Chitosan-Based Microstructured Lipid Carrier (CH-MLC)”
by Marta Guerini, Giorgia Condrò and Paola Perugini
Pharmaceutics 2022, 14(1), 170; https://doi.org/10.3390/pharmaceutics14010170
Available online: https://www.mdpi.com/1999-4923/14/1/170

You can check all publications in the Section “Drug Delivery and Controlled Release” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1031.

We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Biopharmaceutics”. The paper list is as follows:

1. “Strategies for Targeted Delivery of Exosomes to the Brain: Advantages and Challenges”
by Hojun Choi, Kyungsun Choi, Dae-Hwan Kim, Byung-Koo Oh, Hwayoung Yim, Soojin Jo and Chulhee Choi
Pharmaceutics 2022, 14(3) 672; https://doi.org/10.3390/pharmaceutics14030672
Available online: https://www.mdpi.com/1999-4923/14/3/672

2. “The Role of Glucosinolates from Cruciferous Vegetables (Brassicaceae) in Gastrointestinal Cancers: From Prevention to Therapeutics”
by Catarina Melim, Maria R. Lauro, Isabel M. Pires, Paulo J. Oliveira and Célia Cabral
Pharmaceutics 2022, 14(1) 190; https://doi.org/10.3390/pharmaceutics14010190
Available online: https://www.mdpi.com/1999-4923/14/1/190

3. “In Vitro Methodologies for Evaluating Colon-Targeted Pharmaceutical Products and Industry Perspectives for Their Applications”
by Mauricio A. García, Felipe Varum, Jozef Al-Gousous, Michael Hofmann, Susanne Page and Peter Langguth
Pharmaceutics 2022, 14(2), 291; https://doi.org/10.3390/pharmaceutics14020291
Available online: https://www.mdpi.com/1999-4923/14/2/291

4. “Hepatoprotective Effect of Carob Pulp Flour (Ceratonia siliqua L.) Extract Obtained by Optimized Microwave-Assisted Extraction”
by Nikola Martić, Jana Zahorec, Nebojša Stilinović, Bojana Andrejić-Višnjić, Branimir Pavlić, Nebojša Kladar, Dragana Šoronja-Simović, Zita Šereš, Miodrag Vujčić, Olga Horvat et al.
Pharmaceutics 2022, 14(3), 657; https://doi.org/10.3390/pharmaceutics14030657
Available online: https://www.mdpi.com/1999-4923/14/3/657

5. “Investigations on Cellular Uptake Mechanisms and Immunogenicity Profile of Novel Bio-Hybrid Nanovesicles”
by Yi-Hsuan Ou, Jeremy Liang, Wei Heng Chng, Ram Pravin Kumar Muthuramalingam, Zi Xiu Ng, Choon Keong Lee, Yub Raj Neupane, Jia Ning Nicolette Yau, Sitong Zhang, Charles Kang Liang Lou et al.
Pharmaceutics 2022, 14(8), 1738; https://doi.org/10.3390/pharmaceutics14081738
Available online: https://www.mdpi.com/1999-4923/14/8/1738

6. “Oral Lactoferrin Supplementation during Induction Chemotherapy Promotes Gut Microbiome Eubiosis in Pediatric Patients with Hematologic Malignancies”
by Federica D’Amico, Nunzia Decembrino, Edoardo Muratore, Silvia Turroni, Paola Muggeo, Rosamaria Mura, Katia Perruccio, Virginia Vitale, Marco Zecca, Arcangelo Prete et al.
Pharmaceutics 2022, 14(8), 1705; https://doi.org/10.3390/pharmaceutics14081705
Available online: https://www.mdpi.com/1999-4923/14/8/1705

7. “Ultrasound Triggers Hypericin Activation Leading to Multifaceted Anticancer Activity”
by Federica Foglietta, Roberto Canaparo, Simone Cossari, Patrizia Panzanelli, Franco Dosio and Loredana Serpe
Pharmaceutics 2022, 14(5), 1102; https://doi.org/10.3390/pharmaceutics14051102
Available online: https://www.mdpi.com/1999-4923/14/5/1102

8. “Gastrointestinal Fluid Volumes in Pediatrics: A Retrospective MRI Study”
by Matthias Van der Veken, Michael Aertsen, Joachim Brouwers, Cordula Stillhart, Neil Parrott and Patrick Augustijns
Pharmaceutics 2022, 14(9), 1935; https://doi.org/10.3390/pharmaceutics14091935
Available online: https://www.mdpi.com/1999-4923/14/9/1935

9. “Strategies to Overcome Biological Barriers Associated with Pulmonary Drug Delivery”
by Adam J. Plaunt, Tam L. Nguyen, Michel R. Corboz, Vladimir S. Malinin and David C. Cipolla
Pharmaceutics 2022, 14(2), 302; https://doi.org/10.3390/pharmaceutics14020302
Available online: https://www.mdpi.com/1999-4923/14/2/302

10. “Employ of Anthocyanins in Nanocarriers for Nano Delivery: In Vitro and In Vivo Experimental Approaches for Chronic Diseases”
by Ana C. Gonçalves, Amílcar Falcão, Gilberto Alves, João A. Lopes and Luís R. Silva
Pharmaceutics 2022, 14(11), 2272; https://doi.org/10.3390/pharmaceutics14112272
Available online: https://www.mdpi.com/1999-4923/14/11/2272

You can check all publications in the Section “Biopharmaceutics” at the following link:
https://www.mdpi.com/search?journal=pharmaceutics&section=1030.

We are pleased to invite you to read the selected papers in Pharmaceutics (ISSN: 1999-4923) in the Section “Biologics and Biosimilars”. The paper list is as follows:

1. “Plant-Derived Nano and Microvesicles for Human Health and Therapeutic Potential in Nanomedicine”
by Mariaevelina Alfieri, Antonietta Leone and Alfredo Ambrosone
Pharmaceutics 2021, 13(4), 498; https://doi.org/10.3390/pharmaceutics13040498
Available online: https://www.mdpi.com/1999-4923/13/4/498

2. “Cationic Nanoparticle-Based Cancer Vaccines”
by Jeroen Heuts, Wim Jiskoot, Ferry Ossendorp and Koen van der Maaden
Pharmaceutics 2021, 13(5), 596; https://doi.org/10.3390/pharmaceutics13050596
Available online: https://www.mdpi.com/1999-4923/13/5/596

3. “Host Defense Peptide-Mimicking Polymers and Polymeric-Brush-Tethered Host Defense Peptides: Recent Developments, Limitations, and Potential Success”
by Hashem Etayash and Robert E. W. Hancock
Pharmaceutics 2021, 13(11), 1820; https://doi.org/10.3390/pharmaceutics13111820
Available online: https://www.mdpi.com/1999-4923/13/11/1820

4. “Effective Degradation of Gluten and Its Fragments by Gluten-Specific Peptidases: A Review on Application for the Treatment of Patients with Gluten Sensitivity”
by Yakov E. Dunaevsky, Valeriia F. Tereshchenkova, Mikhail A. Belozersky, Irina Y. Filippova, Brenda Oppert and Elena N. Elpidina
Pharmaceutics 2021, 13(10), 1603; https://doi.org/10.3390/pharmaceutics13101603
Available online: https://www.mdpi.com/1999-4923/13/10/1603

5. “Mesenchymal Stem Cell-Derived Extracellular Vesicles as Non-Coding RNA Therapeutic Vehicles in Autoimmune Diseases”
by Olga Martinez-Arroyo, Ana Ortega, Maria J. Forner and Raquel Cortes
Pharmaceutics 2022, 14(4), 733; https://doi.org/10.3390/pharmaceutics14040733
Available online: https://www.mdpi.com/1999-4923/14/4/733

6. “Coincubation as miR-Loading Strategy to Improve the Anti-Tumor Effect of Stem Cell-Derived EVs”
by Alessia Brossa, Marta Tapparo, Valentina Fonsato, Elli Papadimitriou, Michela Delena, Giovanni Camussi and Benedetta Bussolati
Pharmaceutics 2021, 13(1), 76; https://doi.org/10.3390/pharmaceutics13010076
Available online: https://www.mdpi.com/1999-4923/13/1/76

7. “Intracellular Delivery of Active Proteins by Polyphosphazene Polymers”
by Bareera Qamar, Melani Solomon, Alexander Marin, Thomas R. Fuerst, Alexander K. Andrianov and Silvia Muro
Pharmaceutics 2021, 13(2), 249; https://doi.org/10.3390/pharmaceutics13020249
Available online: https://www.mdpi.com/1999-4923/13/2/249

8. “Local Colonic Administration of a Serine Protease Inhibitor Improves Post-Inflammatory Visceral Hypersensitivity in Rats”
by Nikita Hanning, Michelle De bruyn, Hannah Ceuleers, Tim Boogaerts, Maya Berg, Annemieke Smet, Heiko U. De Schepper, Jurgen Joossens, Alexander L. N. van Nuijs, Joris G. De Man et al.
Pharmaceutics 2021, 13(6), 811; https://doi.org/10.3390/pharmaceutics13060811
Available online: https://www.mdpi.com/1999-4923/13/6/811

9. “Computational Design and Biological Evaluation of Analogs of Lupin Peptide P5 Endowed with Dual PCSK9/HMG-CoAR Inhibiting Activity”
by Carmen Lammi, Enrico M. A. Fassi, Jianqiang Li, Martina Bartolomei, Giulia Benigno, Gabriella Roda, Anna Arnoldi and Giovanni Grazioso
Pharmaceutics 2022, 14(3), 665; https://doi.org/10.3390/pharmaceutics14030665
Available online: https://www.mdpi.com/1999-4923/14/3/665

10. “Effects of Polyphenols on P-Glycoprotein (ABCB1) Activity”
by Kuljeet Singh, Szabolcs Tarapcsák, Zsuzsanna Gyöngy, Zsuzsanna Ritter, Gyula Batta, Rosevalentine Bosire, Judit Remenyik and Katalin Goda
Pharmaceutics 2021, 13(12), 2062; https://doi.org/10.3390/pharmaceutics13122062
Available online: https://www.mdpi.com/1999-4923/13/12/2062

You can check all publications in the Section “Biologics and Biosimilars” at the following link: https://www.mdpi.com/search?journal=pharmaceutics&section=1035.

With the first issue released in June 2023, five new MDPI journals disseminating multi-disciplinary science are due to launch, which will cover the subjects of medicine & pharmacology, biology and physical sciences.

The newly launched journals will be overseen by professional Editorial Board Members and Editors to ensure an accurate and rapid publication, rigorous peer review and broad visibility.

Please feel free to browse and discover more about the new journals below.

Journal	Founding Editor-in-Chief	Journal topics (selected)
	Prof. Dr. Jun Ma, Peking University, China| Editorial | view inaugural issue	growth and development; diet and nutrients; school health promotion policies and practices; child health and care; adolescent health and wellbeing | view journal scope | submit an article
	Prof. Dr. Bernd Rehm, Griffith University, Australia | Editorial | view inaugural issue	DNA and gene synthesis; synthetic transcription factors; protein engineering; viral engineering; metabolic engineering | view journal scope | submit an article
	Prof. Dr. Varsha Gandhi, University of Texas MD Anderson Cancer Center, USA | Editorial | view inaugural issue	lymphatics; cancers associated with lymphocytes and lymphoblasts; lymphatic tissues; lymphoma; lymphoid leukemia | view journal scope | submit an article
	Dr. Bradley Turner, University of Melbourne, Australia | Editorial | view inaugural issue	multiple sclerosis; amyotrophic lateral sclerosis; primary lateral sclerosis; atherosclerosis; systemic sclerosis | view journal scope | submit an article
	Prof. Dr. Clemens Burda, Case Western Reserve University, USA | Editorial | view inaugural issue	Gamma ray, X-ray, and UV–Vis spectroscopies; NIR/mid-infrared/Raman spectroscopy; microwave and THz spectroscopy; high-resolution gas-phase atomic, molecular, and cluster spectroscopy; MS, NMR, and EPR spectroscopy | view journal scope | submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to submit an application to the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.